Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

Clinical trial NCT00268918 · COMPLETED

Trial details

NCT number: NCT00268918
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Endometrial Cancer Cervical Cancer Fallopian Tube Cancer Peritoneal Cancer Breast Cancer

Start date: 2005-09-01
Primary completion: 2007-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.